Mirabegron ER & Solifenacin Tablets 25mg/25mg, 25mg/50mg

What is Mirabegron ER & Solifenacin Tablets 25mg/25mg, 25mg/50mg?

Mirabegron ER and Solifenacin Tablets combine mirabegron extended-release with solifenacin in two stated strengths. This oral tablet formulation is used in the management of symptoms associated with overactive bladder, including urinary urgency, increased urinary frequency, and urge urinary incontinence, according to approved product information.

Uses / Indications

Mirabegron ER & Solifenacin Tablets may be used for the management of symptoms associated with overactive bladder, including:

• Urinary urgency
• Increased urinary frequency
• Urge urinary incontinence
• Overactive bladder symptoms that may require combined pharmacological management

The specific indication and strength selected should follow the approved product information and clinical assessment.

Benefits

• Combines two medicines with complementary actions on bladder function.
• Available in the stated 25mg/25mg and 25mg/50mg strengths.
• Provides mirabegron in an extended-release formulation.
• Used for management of multiple overactive bladder symptoms.
• Supplied in Alu-Alu blister packaging for pharmaceutical supply requirements.

Side Effects

Common Side Effects

Possible side effects may include:

• Dry mouth
• Constipation
• Headache
• Dizziness
• Increased blood pressure
• Nausea
• Urinary tract infection

Less Common or Serious Side Effects

Potentially serious effects may include difficulty emptying the bladder, significant increases in blood pressure, severe allergic reactions, or abnormal heart-related symptoms. Seek prompt medical attention if severe or unusual symptoms occur.

How Does It Work?

Mirabegron is a beta-3 adrenergic receptor agonist that promotes relaxation of the bladder detrusor muscle during the storage phase, helping increase bladder capacity. Solifenacin is an antimuscarinic medicine that reduces muscarinic receptor-mediated bladder contractions. Their complementary actions can help address symptoms associated with overactive bladder.

Dosage Guidelines

The appropriate strength and treatment regimen depend on the patient’s symptoms, response to treatment, medical history, kidney and liver function, and other medicines being used.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

For oral tablets:

• Take exactly as prescribed.
• Swallow the tablet with water.
• Because the formulation contains an extended-release component, do not crush, chew, or split the tablet unless specifically permitted by the approved product information.
• Follow the prescribed dosing schedule consistently.
• Do not change between strengths without professional guidance.

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

When Not to Use

The product should not be used in individuals with a known hypersensitivity to mirabegron, solifenacin, or any ingredient in the approved formulation.

Particular clinical conditions may require avoidance, dose adjustment, or specialist supervision. The approved product information should be reviewed before use.

Drug / Product Interactions

Mirabegron and solifenacin can interact with certain medicines. Important interaction considerations may include:

• Medicines that can increase blood levels of solifenacin
• Certain medicines metabolized through relevant cytochrome pathways
• Other medicines with anticholinergic effects
• Medicines that may affect heart rhythm
• Medicines that can increase blood pressure

A complete medication list should be reviewed by a qualified healthcare professional before treatment.

Safety Advice

• Use only according to approved product information and professional guidance.
• Blood pressure should be considered before and during treatment where clinically appropriate.
• Inform the healthcare professional about urinary retention, bladder obstruction, or difficulty emptying the bladder.
• Tell the healthcare professional about glaucoma, significant heart conditions, kidney disease, or liver disease.
• Inform the healthcare professional about all prescription medicines, non-prescription medicines, and supplements being used.
• Seek medical attention for severe allergic reactions, inability to urinate, significant palpitations, or other serious symptoms.

General Instructions

• Take the tablet exactly as prescribed.
• Swallow the tablet whole with water unless the approved product information specifies otherwise.
• Do not crush, chew, or split the extended-release tablet unless specifically permitted.
• Take doses at the prescribed time each day.
• Do not discontinue or change treatment without appropriate professional advice.
• Keep the medicine out of reach of children.

Special Dietary / Lifestyle Tips

Adequate fluid intake should be maintained according to individual medical requirements. Limiting excessive intake of bladder irritants such as caffeinated beverages may be considered for some individuals with overactive bladder symptoms.

Regular bladder habits, appropriate physical activity, and pelvic-floor measures may also form part of an overall management plan where recommended by a healthcare professional.

Comparison with Other Treatments

Mirabegron and solifenacin provide two different pharmacological approaches to managing overactive bladder symptoms. Other treatment options may include an antimuscarinic medicine alone, a beta-3 adrenergic agonist alone, bladder-training measures, pelvic-floor interventions, or other therapies depending on the patient’s condition.

Treatment selection depends on symptoms, previous treatment response, tolerability, medical history, and approved clinical recommendations.

Precautions & Warnings

• Monitor blood pressure where clinically appropriate.
• Use caution in patients with significant urinary retention or bladder outlet obstruction.
• Inform the healthcare professional about glaucoma or other eye conditions.
• Kidney and liver function may be relevant when determining appropriate treatment.
• Review the complete medication profile for potential interactions.
• Seek medical attention if urinary retention develops.
• Use during pregnancy or breastfeeding only according to appropriate professional advice and approved product information.

Can I Use It With Other Medicines?

Generally Compatible With

The combination may be used with other medicines when specifically prescribed and reviewed by a qualified healthcare professional.

Use With Caution / Avoid

Particular caution may be required with other anticholinergic medicines, medicines affecting blood pressure, medicines associated with heart-rhythm effects, and medicines that may alter mirabegron or solifenacin exposure.

Patients should provide a complete list of current medicines and supplements before starting treatment.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep in the original packaging.
• Protect from excessive heat and moisture.
• Keep the blister properly stored until use.
• Keep out of reach of children.
• Do not use after the expiry date.

Frequently Asked Questions

1. What are Mirabegron ER & Solifenacin Tablets used for?

They are used for the management of overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence.

2. What strengths are available?

The stated strengths are Mirabegron ER 25 mg + Solifenacin 25 mg and Mirabegron ER 25 mg + Solifenacin 50 mg.

3. Why are mirabegron and solifenacin combined?

The two medicines act through different mechanisms involved in bladder storage and contraction, providing a combined pharmacological approach to overactive bladder symptom management.

4. What does ER mean in Mirabegron ER?

ER means extended release, indicating that the mirabegron component is formulated for prolonged release after oral administration.

5. Can the tablet be crushed or chewed?

Because it contains an extended-release component, the tablet should not be crushed, chewed, or split unless this is specifically permitted by the approved product information.

6. Can this medicine affect blood pressure?

Mirabegron may increase blood pressure in some individuals. Blood pressure considerations should therefore be discussed with a qualified healthcare professional.

7. What are common side effects?

Possible side effects include dry mouth, constipation, headache, dizziness, increased blood pressure, nausea, and urinary tract infection.

8. How should these tablets be stored?

Store according to the approved product label and package insert, protecting the tablets from excessive heat and moisture and keeping them out of reach of children.